Anglo East Group pleased to represent an excellent and unique stem cell therapy invented and developed by a multi-national healthcare company “TheraVitae” which focused on using the patient’s own cells to treat a variety of disorders, especially cardiovascular diseases. TheraVitae is the only-one company in this planet doing research, develop and able to produce stem cell by using exclusive “TheraVitae” technology. Recently, Anglo East Group representing “TheraVitae” and marketing VesCell
to Malaysia, Indonesia, Hong Kong
and Thailand under “AngloEast-VesCell” named. TheraVitae collaborate with eminent physicians and scientists who are affiliated with well-known medical and academic institutions.
TheraVitae committed to making the benefits of stem cell therapy accessible to all – with integrity, safety and compassion.
VesCell? a product developed by TheraVitae that uses patient’s own adult stem cells to treat severe heart disease.
VesCell – Adult Stem Cell therapy for Heart Disease
Cardiologists and cardiac surgeons are using VesCell to treat no-option
patients suffering from Ischemic Heart Disease (Coronary Artery Disease),
Cardiomyopathy and End-stage Heart Failure by relieving debilitating symptoms
such as severe angina pectoris (chest pain) and shortness of breath.
VesCell – Adult Stem Cell Therapy for PAD (Peripheral Artery Disease)
VesCell PAD is the latest stem cell technology developed by TheraVitae.
It is using patients’ stem cells to treat severe disease of the lower
limbs, enriching blood flow to the affected area and thus avoiding possible
amputation.